TP53 and esophageal squamous cell carcinoma: We looked for such evolutionary pattern in ESCC and also identified prevalence of TP53 inactivation and genome doubling events in the TD cohort, which reminded us that there might be parallels in the general patterns of progression of these two cancer types.